KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Interest Expenses (2016 - 2026)

Evolent Health has reported Interest Expenses over the past 10 years, most recently at $19.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 182.89% year-over-year to $19.0 million; the TTM value through Dec 2025 reached $57.5 million, up 132.47%, while the annual FY2025 figure was $57.5 million, 132.47% up from the prior year.
  • Interest Expenses for Q4 2025 was $19.0 million at Evolent Health, up from $16.5 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $19.0 million in Q4 2025 and troughed at $2.1 million in Q2 2022.
  • A 5-year average of $8.9 million and a median of $6.4 million in 2021 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: crashed 65.76% in 2022 and later soared 573.09% in 2023.
  • Year by year, Interest Expenses stood at $6.4 million in 2021, then fell by 0.28% to $6.4 million in 2022, then surged by 90.36% to $12.2 million in 2023, then plummeted by 45.09% to $6.7 million in 2024, then surged by 182.89% to $19.0 million in 2025.
  • Business Quant data shows Interest Expenses for EVH at $19.0 million in Q4 2025, $16.5 million in Q3 2025, and $11.6 million in Q2 2025.